Esther Rajavelu sold $42K of Spero Therapeutics stock
By AlphaYouPublished Form 4
Rajavelu Esther
Reporting filer
Esther Rajavelu reported selling 40,851 shares of Spero Therapeutics, Inc. for about $42K ($1.04 a share on average). Form 4 filed Nov 10, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Nov 10, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Rajavelu Esther | 2026-11-09 | S | Sale | 40851 | 1.04 | 946,000 | 1 day | Filed terms
|
Common Stock
- Owner
- Rajavelu Esther
- Date
- 2026-11-09
- Code
- S
- Action
- Sale
- Quantity
- 40851
- Price
- 1.04
- Following holdings
- 946,000
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-09
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F1
- transaction Shares: 40851
- id: F1
- transaction Price Per Share: 1.04
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 946000
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Rajavelu Esther: See Remarks, Director.
- F1: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
Original sources
Prepared automatically from public filing data. Report a correction.